S
Scott M. Grundy
Researcher at University of Texas Southwestern Medical Center
Publications - 849
Citations - 246629
Scott M. Grundy is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 187, co-authored 841 publications receiving 231821 citations. Previous affiliations of Scott M. Grundy include University of California, San Francisco & University of California, Davis.
Papers
More filters
Journal Article
Rationale and management of hyperlipidemia of the nephrotic syndrome
Scott M. Grundy,Gloria Lena Vega +1 more
TL;DR: The new drugs that inhibit cholesterol synthesis, e.g., lovastatin, appear to be highly promising for treating elevations of both serum cholesterol and triglycerides in the nephrotic syndrome, but testing of these drugs in this condition has been limited, and the possibility of significant side effects in an appreciable portion of patients has not been ruled out.
Journal ArticleDOI
Relationship of apolipoprotein B levels to the number of risk factors for metabolic syndrome.
TL;DR: Non-HDL-C correlates highly with total apolipoprotein B in patients with metabolic syndrome and had advantages as a target of therapy over LDL-C or NMR apo B.
Journal Article
Guidelines for cholesterol management: Recommendations of the National Cholesterol Education Program's Adult Treatment Panel II
Journal ArticleDOI
Studies on bile acids in rat systemic blood. Bile acids and steroids. 107.
Scott M. Grundy,J. Sjovall +1 more
TL;DR: Championship rats were given tritium labelled cholic acid intraperitoneally or orally and killed by exsanguination after 24 or 48 hours and Chromatographic analysis showed that more unconjugated cholic Acid was present in the systemic blood than in the small intestine.